Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR1894) | ||||||
---|---|---|---|---|---|---|
Drug Name |
ABT-761
|
|||||
Synonyms |
Atreleuton; Atreleuton (USAN/INN); Atreleuton [USAN:INN]; SCHEMBL2108309; U301T88E1M; VIA 2291; VIA-2291; (R)-N-{3-[5-(4-fluorophenylmethyl)thien-2-yl]-1-methyl-2-propynyl)-N-hydroxyurea; (R)-N-{3-[5-(4-fluorophenylmethyl)thien-2-yl]-1-methyl-2-propynyl}-N-hydroxyurea; 154355-76-7; A-85761; A-85761.0; ABT 761; ABT-761; AC1MJ6LB; Abbott-85761; BDBM50029781; CHEMBL59356; CTK4C8218; DTXSID10165598; MMSNEKOTSJRTRI-LLVKDONJSA-N; UNII-U301T88E1M; Urea,N-[(1R)-3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propyn-1-yl]-N-hydroxy-
|
|||||
Indication | Asthma [ICD11: CA23] | Phase 3 | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 318.4 | Topological Polar Surface Area | 94.8 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
Cross-matching ID |
|
|||||
The Predicted Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Predicted Drug Metabolites (PDM) of This Drug | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.